1. Introduction {#s0005}
===============

Psychosis includes a debilitating series of mental illnesses and improving etiological understanding is especially important for designing targeted interventions that may be implemented prior to onset. In recent years, focus of investigation in this area has shifted to also include individuals at ultra-high-risk (UHR) for psychosis, a population where between 15 and 35% of individuals go on to develop a psychotic disorder such as schizophrenia within 2 years ([@bb0065], [@bb0160], [@bb0220]). At the present time, neurodevelopmental and disconnectivity hypotheses have been instrumental in providing a framework for understanding this vital risk period ([@bb0120], [@bb0130]). Within this context, it is important to consider that while there has been very important progress in this area, a sorely needed developmentally-informed perspective remains hampered by the lack of longitudinal studies that included brain data at multiple time points, and consider both structural and functional connectivity.

The cerebellum and cerebello-thalamo-cortical (CTC) networks have been implicated in psychosis, typically as part of a cognitive dysmetria framework ([@bb0020], [@bb0015], [@bb0010], [@bb0180]). Recently, we suggested that cerebellar functional deficits may contribute to symptomatology due to dysfunctional internal models of behavior and altered interactions with the cortex ([@bb0045]). Furthermore, resting state functional connectivity MRI (fcMRI) in UHR individuals demonstrates that cerebello-thalamo-cortical connectivity strength is related to positive and negative symptom severity ([@bb0040]). It may be the case that developmental differences in CTC networks are associated with symptom progression in UHR individuals, and can serve as a possible biomarker of disease progression. However, while there is an emerging literature suggesting cerebellar functional deficits and neural differences in UHR populations ([@bb0040], [@bb0060], [@bb0090], [@bb0085], [@bb0170]), development within CTC networks has not been investigated in UHR populations longitudinally with respect to disease course. Such an investigation would provide key new insights into the role of CTC networks in disease progression and the etiology of schizophrenia and psychosis more broadly.

In this study, we investigated a sample of UHR and healthy control adolescents to investigate two questions. First, does cerebello-thalamo-cortical network development (functional and structural) differ between healthy adolescents and UHR individuals? Second, does CTC network activity relate to disease progression in this population? We focused on cerebellar Lobule V and Crus I and II; in patients with schizophrenia, motor abnormalities including (e.g., deficits in postural control and motor learning; [@bb0145], [@bb0140]), particularly as they relate to the cerebellum, are well-defined (reviewed in [@bb0030], [@bb0035]), and cognitive dysfunction represents a core deficit of the disease ([@bb0110]) making these networks particularly interesting targets of investigation. In our recent work investigating structural and functional network development during adolescence in healthy controls we found that functional connectivity between Crus I and II with lateral and medial prefrontal cortex is decreased over 12-months. This stands in contrast with Lobule V, a key motor network, where there are no further changes. These findings suggest that development of cerebello-frontal networks is protracted relative to motor development ([@bb0050]). Thus, we hypothesized that functional connectivity development in the UHR group would differ with respect to controls. With respect to Crus I and Crus II connectivity we predicted that this would be manifest in one of two ways: as increases over time, or no changes. In normally developing youth, there were no changes in Lobule V connectivity in healthy controls ([@bb0050]); therefore, we expected to see either increases or decreases in the UHR group indicative of abnormal developmental patterns. Regarding white matter, consistent with our prior work investigating white matter development in UHR populations ([@bb0045], [@bb0165]), we predicted that there would be a significant interaction such that FA would decrease in the UHR group, but increase in controls. We expected a smaller degree of change in the Lobule V white matter networks given the normative developmental patterns of motor regions ([@bb0050]). Finally, we hypothesized that both functional and structural measures of cerebello-thalamo-cortical connectivity would be associated with symptom progression in the UHR group.

2. Methods {#s0010}
==========

2.1. Participants {#s0015}
-----------------

Adolescents between 12 and 21 years old were recruited at the Adolescent Development and Preventive Treatment (ADAPT) program and the Institutional Review Board approved all procedures. Exclusion criteria for both groups included history of head injury, the presence of a neurological disorder, life-time substance dependence as assessed by the Structured Clinical Interview for Axis-I DSM-IV Disorders ([@bb0115]), and the presence of any contraindications for the magnetic resonance imaging environment. For UHR participants, we also excluded those with an Axis I psychotic disorder. In control subjects, we excluded all those with an Axis I disorder, or the presence of a psychotic disorder in first-degree relatives.

In total, 68 UHR and 78 control participants have been enrolled in the study. At the time of this investigation, 36 UHR and 42 control individuals were eligible for 12-month follow-up. 8 UHR individuals were lost to attrition, and 2 were excluded from our analysis due to issues with brain imaging data quality. Of the controls, 3 declined to complete the baseline scan, and 5 declined to complete the scan at 12-month follow-up. 7 control participants were lost to attrition. This level of attrition is largely comparable to other longitudinal studies following this population ([@bb0065]). Finally, 3 additional participants were excluded due to issues with data quality and collection at the scanner. Our final sample for analysis included 26 UHR (18.65 ± 1.74 years old, 8 female, 4 left-handed) and 24 control (17.83 ± 2.50 years old, 13 female, 1 left-handed) participants who were assessed with a clinical interview and completed a neuroimaging session at both baseline and 12-month follow-up. Given that left-handedness is more common in patients with schizophrenia ([@bb0100]), the inclusion of left-handed individuals results in a more representative high-risk sample. Analyses with these individuals removed are presented in the Supplemental material. Demographic variables are presented in [Table 1](#t0005){ref-type="table"}.Table 1Demographic variables and symptom severity in UHR and control participants. Mean and standard deviation are presented. Statistical significance, in cases where there is a trend or significant group difference is provided. Positive and negative symptoms differed significantly at both baseline and follow-up. Specific *p*-values and statistics are provided in text.Table 1UHRControlN26\
(8 female)24\
(13 female)Baseline Age (years)18.65\
(1.74)17.83\
(2.50)Parent education (years)16.63\
(1.82)16.29\
(2.40)Subject education (years)12.77\
(1.73)11.95\
(2.42)Alcohol frequency[⁎](#tf0010){ref-type="table-fn"}1.96\
(1.82)0.96\
(1.08)Positive symptoms[⁎⁎⁎](#tf0015){ref-type="table-fn"}Baseline11.96\
(3.69)0.58\
(1.21)Follow-up11.04\
(6.77)0.08\
(0.28)Negative symptoms[⁎⁎⁎](#tf0015){ref-type="table-fn"}Baseline10.85\
(6.95)0.42\
(0.77)Follow-up7.27\
(6.43)0.25\
(0.53)Scanner motion (mm)Baseline0.26\
(0.34)0.21\
(0.47)Follow-up0.30\
(0.34)0.21\
(0.10)Scanner outliers (number)Baseline[\#](#tf0005){ref-type="table-fn"}5.27\
(4.63)8.08\
(6.30)Follow-up8.07\
(10.52)4.67\
(5.52)[^1][^2][^3]

Longitudinal data from the healthy control participants included have been analyzed previously as part of an investigation on cerebellar development ([@bb0050]). Here, the control subjects are identical to those used in ([@bb0050]), and serve as a point of comparison for our UHR group. All analyses presented here are entirely new, and focus on group differences, or within group analyses of the UHR sample, which has not been studied in this context. Subsets of the UHR data have been investigated longitudinally ([@bb0045], [@bb0090], [@bb0165]), but this work has not focused on fcMRI with respect to symptom progression. Indeed, to our knowledge this represents the first longitudinal multimodal imaging study of UHR individuals with respect to symptom progression.

2.2. Symptom assessment {#s0020}
-----------------------

The Structured Interview for Prodromal Syndromes (SIPS) measures distinct categories of prodromal symptom domains including positive and negative dimensions and is scored from 0 to 6 for each symptom. Inclusion in the UHR group was determined by moderate levels of positive symptoms (a SIPS score of 3--5 in one or more of the 5 positive symptom categories; [Table 1](#t0005){ref-type="table"}), and/or a decline in global functioning in association with the presence of schizotypal personality disorder, and/or a family history of schizophrenia ([@bb0155]). A total of 3 UHR participants (12.5%) had a family history of schizophrenia, and two of these individuals showed attenuated positive symptoms as well. All interviewers had inter-rater reliabilities that exceeded Kappa ≥ 80. The SIPS was administered at baseline to confirm a prodromal syndrome and include individuals in the UHR group, and at 12-month follow-up to assess symptom change. We quantified total positive and negative symptoms for our subsequent analyses. The frequency of alcohol consumption was measured based on self-report on a scale from 0 to 5 where 0 indicates "never uses" and 5 indicates "almost daily use" ([@bb0105]).

2.3. Comorbidities {#s0025}
------------------

Consistent with other reports ([@bb0125], [@bb0190]), the UHR group comorbidities included major depressive disorder (n = 5, 20.1%), dysthymic disorder (n = 1, 4%), bipolar disorder (n = 3, 12.5%), obsessive compulsive disorder (n = 1, 4%), post-traumatic stress disorder (n = 1, 4%), anxiety disorders (n = 7, 29.2%).

2.4. Neuroimaging procedure, data preprocessing and analysis {#s0030}
------------------------------------------------------------

Participants completed a brain imaging session that included structural, fcMRI, and DTI scans, acquired using a 3-Tesla Siemens Tim Trio MRI scanner (Siemens AG, Munich, Germany) using a standard 12-channel head coil. All fcMRI data were pre-processed using FSL (v.5.0.7; <http://fsl.fmrib.ox.ac.uk/fsl>), and analysis was performed in the CONN toolbox version 15.a ([@bb0215]) implemented with SPM 12 (Wellcome Trust Centre for Neuroimaging). Cerebello-thalamo-cortical white matter tracts were mapped for Lobule V as well as Crus I. These tracts have been previously well delineated in healthy adults ([@bb0195]), thus we restricted our tractography to these regions, and used methods identical to those in our work looking at healthy development ([@bb0050]). Diffusion weighted images were processed using FSL\'s FDT toolbox. The parameters used for data collection and preprocessing match closely those used in our previously published brain imaging work (e.g., [@bb0050], [@bb0030], [@bb0035], [@bb0045]). Specific details are provided in the Supplemental material.

First, we conducted analyses to investigate developmental differences in the Lobule V, Crus I and Crus II networks in UHR and control individuals using group x time repeated measures ANOVAs in the CONN toolbox. This was followed up with within-subjects paired *t*-tests of the UHR group to better understand the within-group patterns of cerebello-cortical resting state development. Finally, we conducted correlation analyses within the CONN toolbox to determine whether baseline connectivity patterns are correlated with symptom change at the whole-brain level, and to investigate the relationships between structural and functional connectivity. All resulting statistical maps were first thresholded at the voxel-level at p~uncorr~ \< 0.001 and corrected at the cluster-level to a false-discovery rate (FDR) of *p* \< 0.05 ([@bb0080]). Because this is an important clinical population, we also reported trend-level findings (p~FDR~ \< 0.08), as these trends may be of clinical importance.

Mean FA was then extracted for each person from the tracts connecting Lobule V to the motor cortex, and Crus I to the prefrontal cortex (both via the thalamus) by masking the FA maps with masks of the respective tracts. We have also previously investigated these tracts in healthy controls only ([@bb0050]), and found there is good correspondence with those mapped by Salmi and colleagues ([@bb0195]). We refer readers to our prior work, which shows in detail these tracts as they were mapped here in the healthy control participants ([@bb0050]).

2.5. Additional statistical analyses {#s0035}
------------------------------------

Demographic, symptom, and measures of FA from our DTI scans were analyzed IBM SPSS 22 (IBM Corporation Armonk, NY, 2012). Group differences in demographic variables were analyzed using independent samples *t*-tests (analysis of demographic variables, symptomatology, psychiatric comorbidities and scanner motion are presented in the Supplemental material). Changes in symptoms over time, motion, and FA in the individual tracts of interest were all analyzed using 2 × 2 group by time repeated measures ANOVA. Analyses of the relationships between FA and symptom severity were conducted using Pearson correlation and linear modeling. We were interested in understanding how changes in white matter relate to symptom progression, and as such we used a difference score (time 2--time 1). To understand how functional and structural connectivity at baseline together act as a marker of disease severity at time 2 (quantified as symptom severity), we used stepwise regression models, that were again initially limited to cerebello-thalamo-motor connectivity. Stepwise regression models were subsequently computed using connectivity between Lobule V and M1, in conjunction with baseline FA to predict symptom severity at 12-month follow-up. In all cases, unless otherwise noted in the results section, statistics were evaluated using *p* \< 0.05.

3. Results {#s0040}
==========

3.1. Resting state connectivity development in UHR individuals {#s0045}
--------------------------------------------------------------

We found a significant interaction with Crus I, wherein connectivity between Crus I and the occipital cortex was different over time in the two groups ([Table 2](#t0010){ref-type="table"}), supporting a differential pattern of development in UHR individuals. To further unpack these results we conducted within group analyses of connectivity change in the UHR group, comparing Time 2 to Time 1. Consistent with predictions, we found a different pattern of development in the cerebello-prefrontal resting state networks associated with the Crus I and Crus II seed regions. In the UHR group, we observed no differences in functional connectivity in Crus I and Crus II when conducting a paired *t*-test comparing the two time points, unlike our results in healthy controls ([@bb0050]). However, consistent with our findings in healthy controls, there were no differences over time in Lobule V connectivity in the UHR group. Supplementary Fig. 2 presents the within-group patterns of cerebello-cortical connectivity at follow-up, while Supplementary Table 3 presents group differences.Table 2Group by Time interaction Crus I.Table 2Seed regionRegionBACluster sizeMNI coordinatesT-valueP~(FDR)~XYZCrus IOccipital pole182168− 92124.160.008Supracalcarine cortex184− 8683.62

3.2. Resting state connectivity and symptom progression in UHR individuals {#s0050}
--------------------------------------------------------------------------

To evaluate the utility of baseline connectivity as a marker of symptom progression in UHR populations, we investigated correlations between baseline connectivity and both positive and negative symptom change. With respect to positive symptoms, we found that functional connectivity between the cerebellum and cortex using all cerebellar seeds was positively associated with worsening positive symptoms. In Lobule V, higher connectivity in the medial motor regions, supplementary motor area, and the thalamus at baseline were associated with worsening symptoms over 12-months, though the thalamus finding was trend-level. In both Crus I and II, connectivity with the cingulate cortex was associated with worsening symptoms (see [Fig. 1](#f0005){ref-type="fig"} and Supplementary Table 4). There were no significant associations with respect to baseline connectivity and negative symptom change.Fig. 1Correlations between baseline cerebello-cortical connectivity and positive symptom change. A. Lobule V (left medial), B. Crus I (left medial), and C. Crus II (left medial) networks. In all cases, higher connectivity at baseline was associated with worsening positive symptoms. For Lobule V, the medial motor cortical regions are presented on the inflated medial surface, while thalamic connectivity is presented on an axial slice. Coordinates of the significant regions and the associated statistics are presented in [Table 3](#t0015){ref-type="table"}. L: left hemisphere; R: right hemisphere. Figure depicts the z-scores of connectivity from the r-to-z transform computed in CONN.Fig. 1

3.3. White matter development and symptom progression in UHR individuals {#s0055}
------------------------------------------------------------------------

Investigations using paired *t*-tests in the UHR group alone found that there were no significant differences in any of the tracts over the course of one year (Lobule V-thalamic: t~(25)~ = 1.12, *p* = 0.27; Crus I-thalamic: t~(25)~ = 0.94, *p* = 0.35; thalamo-motor: t~(25)~ = 0.14, *p* = 0.89; thalamo-prefrontal: t~(25)~ = 1.35, *p* = 0.19). Using 2 × 2 (group × time) ANOVAs to look at each of the four tract segments, we found trend-level interactions after correcting for multiple comparisons (Bonferroni, *p* \< 0.0125) in FA in the Lobule V-thalamic tract segment (F~(1,48)~ = 5.02, *p* = 0.03), the thalamo-prefrontal tract segment (F~(1,48)~ = 4.42, *p* = 0.041), and the Crus I-thalamic tract segment (F~(1,48)~ = 3.59, *p* = 0.064). There was no significant group by time interaction in the thalamo-motor tract (F~(1,48)~ = 1.73, *p* = 0.195). Thus, there is a trend that suggests an abnormal pattern of development in cerebello-thalamo-cortical white matter in UHR individuals (Supplementary Fig. 3).

Pairwise correlations between FA change in the four tracts of interest and both positive and negative symptom change were completed, and analyses were Bonferroni corrected to *p* \< 0.006. There was a positive correlation between FA change in the thalamo-motor tract and positive symptom change (r~(26)~ = 0.54, *p* = 0.004; [Fig. 2](#f0010){ref-type="fig"}), after correction for multiple comparisons. None of the other correlations were significant (in all cases, *p* \> 0.27) with respect to positive symptoms, and there were no significant correlations with negative symptoms (in all cases *p* \> 0.31). In conjunction with the resting state connectivity data, this provides converging evidence suggesting that cerebello-thalamo-motor tracts are related to positive symptom progression in UHR individuals. In the UHR sample, those with FA increases were those that were worsening over time with respect to symptoms, while those with FA decreases showed improving symptoms.Fig. 2FA change and positive symptom progression. FA change in the thalamo-motor tract was significantly positively associated with worsening positive symptoms using a linear model. Those with continued increases in FA had more positive symptoms at 12-months, indicative of a poor disease course. However, a quadratic model fits the data equally well, such that those UHR individuals with the greatest degree of change (increase or decrease) in FA are those that show the largest increases in positive symptom progression. Points shown in red indicate the three individuals who received a conversion diagnosis at 12-month follow-up.Fig. 2

Furthermore, visual inspection of the scatterplot of this relationship indicated that a quadratic relationship may also fit the data. We therefore computed an exploratory analysis of a quadratic model. The quadratic model was significant (R^2^ = 0.383, F~(2,23)~ = 7.15, *p* = 0.004), such that those that show *either* decreases or increases in FA in this tract are those with the greatest changes in positive symptom severity. The greatest deviations in white matter (from no change) were associated with worsening positive symptoms. Finally, 3 UHR participants received a conversion diagnosis of a psychotic disorder during the 12-month follow-up period. They are highlighted in [Fig. 2](#f0010){ref-type="fig"}. Those that converted showed the some of the greatest changes in white matter FA (either increases or decreases). However, there were individuals with comparable degrees of white matter change that did not convert. Additional follow-up on these individuals is ongoing.

3.4. Resting state connectivity, white matter, and symptom progression {#s0060}
----------------------------------------------------------------------

Using step-wise multiple regression we investigated both baseline Lobule V-motor resting state connectivity strength and thalamo-motor FA, with positive symptoms at 12-months as the dependent variable. In the first block of our analysis we entered baseline positive symptoms; we then entered baseline fcMRI strength and FA in blocks 2 and 3, respectively. The model was significant (F~(3,25)~ = 9.36, *p* \< 0.001) and accounted for approximately 56% of the variance in time 2 positive symptoms. The inclusion of baseline Lobule V-motor connectivity strength accounted for 9% of the variance in symptoms at follow-up. The inclusion of Lobule V-motor connectivity represents a statistically significant improvement in the model, as revealed by a significant ΔR^2^. Thalamo-motor FA did not significantly improve the model. Specific statistics regarding this model are provided in [Table 3](#t0015){ref-type="table"}. Notably, the order in which the resting state and FA variables were entered does not change the model or the betas. Results including Crus I and II in the model are presented in the Supplemental material. Future work with larger samples is warranted to follow-up on the impact and utility of these cerebello-frontal networks in predicting positive symptoms over time. Our results here however suggest that baseline cerebello-motor connectivity is a potentially important predictor of time 2 positive symptoms.Table 3Baseline connectivity predicts time 12-month symptoms. Results of the step-wise regression investigating time two positive symptoms. Baseline positive symptoms were entered in the first block, followed by Lobule V-motor cortex connectivity, and thalamo-motor FA. Significant changes in R^2^ are indicated, as are significant β-values. \**p* \< 0.05, \*\*\**p* \< 0.001 Thalamo-Motor FA.Table 3Baseline positive symptomsLobule V-motor connectivityThalamo-motor FAR^2^dfFPΔR^2^dfFPΔR^2^dfFPT2 positive symptoms0.4621,2420.610.000^⁎⁎⁎^0.0901,234.610.04\*0.0091,220.4460.51β0.680^⁎⁎⁎^0.30^⁎^− 0.095

4. Discussion {#s0065}
=============

In taking a longitudinal approach and combining functional and structural neuroimaging measures, the present study found that UHR individuals show abnormal patterns of cerebello-thalamo-cortical network development. Furthermore, in the UHR group alone, both functional and structural measures of cerebello-thalamo-cortical connectivity were associated with positive symptom progression over the course of one year. To our knowledge, this is the first study of a UHR sample to investigate longitudinal symptom progression with respect to changes in fcMRI and DTI. Notably, abnormal FA development in the UHR group was associated with disease progression, and *baseline* connectivity measures are associated with symptom change. Interestingly, these associations were present for the cerebello-thalamo-motor networks in both domains, providing converging evidence for the importance of this circuit in the pathophysiology of psychosis. Most importantly, when baseline Lobule V-motor functional connectivity was included in regression models that account for baseline positive symptoms, there were significant improvements in the amount of variance explained. That is, higher connectivity at baseline was associated with worse positive symptoms 12-months later.

Broadly, these findings indicate CTC circuit developmental abnormalities in UHR individuals. Though speculative, this may be due to delayed neuronal maturity, similar to what was proposed by Insel ([@bb0130]). In younger adults, functional networks between the cerebellum and prefrontal cortex show continued development in later adolescence ([@bb0050]). Here, in the UHR group, we did not see any significant development in these networks over 12-months. Furthermore, patterns of FA changes over time differ in the UHR and control groups at the trend level (after conservative multiple-comparisons corrections). These patterns are consistent with abnormal cerebello-cortical connectivity in schizophrenia ([@bb0205]). Schizophrenia patients show decreased prefrontal-cerebellar connectivity with Crus I and Crus II ([@bb0185], [@bb0205]), where we see abnormal developmental patterns. Abnormal development may contribute to the aberrant patterns present later in the disease.

Cerebellar networks, particularly those between Lobule V and the motor cortex were shown here to be associated with positive symptom change over 12-months in UHR individuals. In the case of Lobule V- motor connectivity, this may be indicative of abnormal sensorimotor integration. Such deficits may contribute to unusual thoughts and hallucinations as the individual is unable to effectively integrate this information or attribute its source ([@bb0045]). Increased cerebellar connectivity with these regions may be indicative of abnormal sensorimotor integration processes at baseline that contribute to later disease progression. Shergill and colleagues have suggested that abnormal sensory prediction error may be related to the positive symptoms of schizophrenia, and linked hallucinations with sensorimotor cortical activation ([@bb0200]). Indeed, recent work has demonstrated that there is hyper-connectivity between the cerebellum and motor networks ([@bb0205]), and heightened thalamo-motor connectivity is seen in UHR individuals that convert to psychosis ([@bb0025]), further highlighting the importance of this connectivity pattern. Thus, while one might expect to see frontal regions associated with positive symptom progression, a growing literature implicates sensorimotor cortex, and here, motor regions of the cerebellum. We suggest that forward modeling and sensory prediction may be especially important for positive symptom progression.

Somewhat surprisingly, we did not see any associations between cerebello-thalamo-cortical connectivity and negative symptom progression. Our own work, and that from others has linked the cerebellum and cerebellar-mediated behavior to negative symptoms ([@bb0040], [@bb0090], [@bb0095]). However, a recent review of negative symptoms has largely implicated cortico-striatal, frontal, and temporal circuits ([@bb0150]). While the authors acknowledge that the cerebellum and thalamus may contribute to negative symptom severity ([@bb0150]), our findings here suggest that cerebello-thalamo-cortical networks may not contribute to progression. Finally, it is notable that on average we see an improvement in negative symptom severity in the UHR group and this may have impacted our ability to detect any predictive value in the negative symptom domain.

Though we found interesting associations between FA change and symptom change, it is notable that FA was initially higher in the UHR group, and the decreases over time may be a normalizing of sorts. With that in mind, it appears to be the case that in this group, any additional change over the 12-month period is associated with worsening positive symptoms. In UHR individuals where there are increases in FA, while this pattern is consistent with that seen in normative development (e.g [@bb0130]), it may be making matters worse. Those that show decreases in FA may be normalizing, or this may also be the start of a downward trend such that FA continues to decrease as they progress further through the course of the disease. These findings are certainly somewhat surprising and counterintuitive, and the best way to resolve them is with further longitudinal follow-up. Furthermore, as the literature on white matter in psychosis risk grows, it seems to be the case that the results themselves are highly mixed ([@bb0055], [@bb0075], [@bb0135]). It does not seem to be the case that simply high or low FA values are consistently found; rather, there are widespread anomalies in FA that speak to broader aberrant developmental.

While our results provide key new findings with respect to cerebello-thalamo-cortical network development in psychosis risk and their contributions to positive symptom progression, several limitations need to be considered. First, while the present sample size is comparable to or larger than other longitudinal DTI studies in this population (17--37 people) ([@bb0055], [@bb0175], [@bb0210]), consortiums combining data from a number of different recruitment centers show significant promise for investigating brain changes in UHR populations ([@bb0070]), and are important for replication. Second, though consistent with recent conversion rates in UHR groups ([@bb0220]), only 3 participants received conversion diagnoses during the 12-month follow-up period. As such, we were unable to look at differences in conversion, and had to focus solely on symptom progression. Furthermore, we refer to conversion broadly, and this is not specific to schizophrenia, consistent with the standard in the prodromal field ([@bb0065]). Relatedly, when we examine the UHR group as a whole, on average there is no significant increase in positive symptoms. With that said, it is important to keep in mind that UHR populations are very heterogeneous and a large majority do not convert ([@bb0005]). Identifying factors that identify the smaller but clinically signficant group that will experience an escalating course of illness is therefore critical. Our DTI findings largely point to thalamic-connectivity. We may have picked up on a thalamic effect. While the resting state findings implicate the cerebello-thalamo-cortical circuit more broadly, future work teasing apart the relative contribution of the cerebellum and thalamus is needed, particularly given recent findings focused on the thalamus ([@bb0025]). Finally, the association between thalamo-motor FA change and time two positive symptoms was in a tract that shows no changes in FA over time. Thus, interpretation of this finding is somewhat difficult. However, we suggest that this is perhaps due to the heterogeneity of the UHR sample with respect to FA change (as seen in [Fig. 2](#f0010){ref-type="fig"}). This is certainly a complex finding, and follow-up work is necessary to better understand the implications.

Together, this investigation provides further support for complementary neurodevelopmental and disconnectivity models, and implicates the cerebellum and its networks with the cortex in the progression of symptoms. While this work is only a first step, it suggests that the cerebellum and its networks may be an especially useful target of research and remediation.
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[^1]: *p* \< 0.1.

[^2]: *p* \< 0.05.

[^3]: *p* \< 0.001.
